Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Fuller

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Journal of Organic Chemistry|January 26, 2010
Mechanistic pathways in CF3COOH-mediated deacetalization reactionsWei Li, Jianchang Li, Yuchuan Wu, et al.
Scientific Reports|June 7, 2016
Perceptual Modalities Guiding Bat Flight in a Native HabitatZhaodan Kong, Nathan Fuller, Shuai Wang, et al.
Drug Discovery Today|May 16, 2016
An improved model for fragment-based lead generation at AstraZenecaNathan Fuller, Loredana Spadola, Scott Cowen, et al.
Journal of Medicinal Chemistry|September 4, 2009
Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthmaWei Li, Jianchang Li, Yuchuan Wu, et al.
Bioorganic & Medicinal Chemistry Letters|December 14, 2011
Discovery of potent and selective matrix metalloprotease 12 inhibitors for the potential treatment of chronic obstructive pulmonary disease (COPD)Yuchuan Wu, Jianchang Li, Junjun Wu, et al.
Journal of Medicinal Chemistry|June 6, 2020
Fragment-based Differential Targeting of PPI Stabilizer InterfacesXavier Guillory, Madita Wolter, Seppe Leysen, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Journal of Organic Chemistry|January 26, 2010
Mechanistic pathways in CF3COOH-mediated deacetalization reactionsWei Li, Jianchang Li, Yuchuan Wu, et al.
Scientific Reports|June 7, 2016
Perceptual Modalities Guiding Bat Flight in a Native HabitatZhaodan Kong, Nathan Fuller, Shuai Wang, et al.
Drug Discovery Today|May 16, 2016
An improved model for fragment-based lead generation at AstraZenecaNathan Fuller, Loredana Spadola, Scott Cowen, et al.
Journal of Medicinal Chemistry|September 4, 2009
Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthmaWei Li, Jianchang Li, Yuchuan Wu, et al.
Bioorganic & Medicinal Chemistry Letters|December 14, 2011
Discovery of potent and selective matrix metalloprotease 12 inhibitors for the potential treatment of chronic obstructive pulmonary disease (COPD)Yuchuan Wu, Jianchang Li, Junjun Wu, et al.
Journal of Medicinal Chemistry|June 6, 2020
Fragment-based Differential Targeting of PPI Stabilizer InterfacesXavier Guillory, Madita Wolter, Seppe Leysen, et al.
Pageof 1